Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3496-3504

  Doctor, R Brian ^a   Serkova, Natalie J ^a,b   Hasebroock, Kendra M ^a   Zafar, Iram ^a   Edelstein, Charles L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Autosomal dominant polycystic kidney disease (ADPKD); Fast imaging with steady state precision (FISP); Magnetic resonance imaging (MRI)

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GRAVIMETRY; GROWTH RATE; KIDNEY CYST; KIDNEY MASS; KIDNEY SIZE; LIVER CYST; LIVER SIZE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PKD2 GENE; PRIORITY JOURNAL; SEX DIFFERENCE; ANIMAL; C57BL MOUSE; CYST; DISEASE MODEL; GENETICS; HUMAN; IMAGE ENHANCEMENT; KIDNEY; KIDNEY POLYCYSTIC DISEASE; LIVER; LIVER DISEASE; METHODOLOGY; MOUSE MUTANT; PATHOLOGY;

POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN;

ANIMALS; CYSTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE ENHANCEMENT; KIDNEY; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TRPP CATION CHANNELS;

EID: 79952202391     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq195     Document Type: Article

References (27)

1. Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009; 60: 321-337
2. Wall WJ. Liver transplantation for polycystic liver disease. N Engl J Med 2007; 356: 1560 (Pubitemid 46588420)
3. King BF, Reed JE, Bergstrahl EJ, Sheedy PF, Torres VE. Quantification and longitudinal trends of kidney, renal cyst and renal parenchymal volumes in ADPKD. J Am Soc Nephrol 2000; 11: 1505-1511 (Pubitemid 30483467)
4. Sise C, Kusaka M, Wetzel LH et al. Volumetric determination of progression in ADPKD by computed tomography. Kidney Int 2000; 58: 2492-2501
5. Chapman AB, Guay-Woodford LM, Grantham JJ et al. Renal structure in early ADPKD: The consortium for radiologic imaging studies of polycystic kidney disease cohort. Kidney Int 2003; 64: 1035-1045 (Pubitemid 37013840)
6. Lee YR, Lee KB. Reliability of MRI for measuring the volumetric indices in ADPKD: Correlation with hypertension and renal function. Nephron Clin Pract 2006; 103: C173-c180
7. Kistler AD, Poster D, Krauer F et al. Increases in kidney volume in ADPKD can be detected within 6 months. Kidney Int 2009; 75: 235-241
8. Everson GT, Scherzinger A, Berger-Leff N et al. Polycystic liver disease: Quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts. Hepatology 1988; 8: 1627-1634 (Pubitemid 19021899)
9. Bae KT, Zhu F, Chapman AB et al. MRI evaluation of hepatic cysts in early ADPKD. Clin J Am Soc Nephrol 2006; 1: 64-69
10. Wu G, D'Agati V, Cai Y et al. Somatic inactivation of Pkd2 results polycystic kidney disease. Cell 1998; 93: 177-188 (Pubitemid 28180852)
11. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilinson JE, Stringer KA. Utility of MRI and NMR-based metabolomics for quantification of inflammatory lung injury. Am J Physiol 2008; 295: L152-L161
12. Troiani T, Serkova NJ, Gustafson KL et al. Investigation of two dosing schedules of vandetanib (ZD6474) in combination with irinotecan in a human colon cancer xenograft model. Clin Cancer Res 2007; 13: 6450-6458
13. Weidensteiner C, Rausch M, McSheeny PM, Allegrini PR. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T. J Magn Reson Imaging 2006; 24: 646-656 (Pubitemid 44320569)
14. Herborn CU, Vogt F, Lauenstein TC, Goyen M, Debatin JF, Ruehm SG. MRI of the liver: Can true FISP replace HASTE. J Magn Reson Imaging 2003; 17: 190-196 (Pubitemid 36151007)
15. Hecht EM, Lee VS, Tanpitukpongse TPet al. MRI of pelvic floor dysfunction: Dynamic true FISP versus HASTE. AJR Am J Roentgenol 2008; 191: 352-358
16. Pei XL, Xie JX. Functional MRI: Evaluation of chronic kidney disease with perfusion imaging. Acad Radiol 2009; 16: 88-95
17. Grantham JJ. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359: 1477-1485
18. Belibi FA, Edelstein CL. Unified ultrasonographic diagnostic criteria for polycystic kidney disease. J Am Soc Nephrol 2009; 20: 6-8
19. Serkova NJ, Garg K, Bradshaw-Pierce EL. Oncologic imaging endpoints for the assessment of therapy response. Recent Pat Anticancer Drug Discov 2009; 4: 36-53
20. Towner RA, Yamaguchi T, Philbrick FJ, Holub BJ, Janzen EG, Takahashi H. In vivo proton MRI and localized spectroscopic analysis of PKD in DBA/2FG-pcy mice. Magn Reson Imaging 1991; 9: 429-434
21. Sun Y, Zhou J, Stayner C et al. MRI assessment of a murine model or recessive polycystic kidney disease. Comp Med 2002; 52: 433-438 (Pubitemid 35252529)
22. Kobayashi H, Kawamoto S, Brechbiel MWet al. Micro-MRI methods to detect renal cysts in mice. Kidney Int 2004; 65: 1511-1516
23. Wallace DP, Hou YP, Huang ZL et al. Tracking kidney volume in mice with polycystic kidney disease by MRI. Kidney Int 2008; 73: 778-781 (Pubitemid 351323259)
24. Wu G, Markowitz GS, Li L et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2 mice. Nat Genet 2000; 24: 75-78 (Pubitemid 30041425)
25. Grantham JJ, Torres VE, Chapman AB et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354: 2122-2130 (Pubitemid 43736612)
26. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033-1037 (Pubitemid 20221041)
27. Shrestha R, Mckinley C, Russ P et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with ADPKD. Hepatology 1997; 26: 1282-1286 (Pubitemid 27509314)